ALK-positive adult histiocytosis with a TFG-ALK fusion gene
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf221 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Oncologist, 2025. Verfasst von Ji Yun Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620, Korea. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Histiocytosis, Oncogene Proteins, Fusion. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea.
Abstract (Originalsprache)
ALK-positive histiocytosis is a rare condition that can affect multiple systems in infants and adults. We identified a rare case of ALK-positive histiocytosis with fusion of the ALK gene with TFG. A 35-year-old previously healthy male has been complaining of back and hip discomfort for seven months. A radiologic examination of the spine and pelvis revealed several hypermetabolic osteolytic lesions. Immunostaining for LCA, CD68, CD117and ALK were positive, whereas immunostaining for CD1a, Langerin, and S100 were negative. Analysis with fluorescence in situ hybridization (FISH) confirmed the ALK rearrangements, and next-generation sequencing (NGS) revealed the fusion of the TFG and ALK genes. After receiving alectinib, an ALK inhibitor of the second generation, the patient showed a durable remission. ALK-positive histiocytosis is a distinct form of histiocytosis that has the potential to be treated with an ALK inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620, Korea.
- Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620, Korea.
- Precision Medicine Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620, Korea.
Förderung
- National R&D Program for Cancer Control
- Ministry of Health and Welfare
- Republic of Korea
- Oncology Precision Medicine Research
Zitieren
APA
Lee, J. Y., Lee, K. R., Na, S., Na, H. Y., Lee, S., Kim, S. A., Lee, J. O., Bang, S. M., Kim, J. H., & Paik, J. H. (2025). ALK-positive adult histiocytosis with a TFG-ALK fusion gene. The Oncologist. https://doi.org/10.1093/oncolo/oyaf221
Vancouver
Lee JY, Lee KR, Na S, Na HY, Lee S, Kim SA, et al. ALK-positive adult histiocytosis with a TFG-ALK fusion gene. The Oncologist. 2025. doi:10.1093/oncolo/oyaf221
BibTeX
@article{Lee2025,
author = {Lee, Ji Yun and Lee, Ki Rim and Na, Sei and Na, Hee Young and Lee, Sejoon and Kim, Sang-A and Lee, Jeong-Ok and Bang, Soo-Mee and Kim, Jee Hyun and Paik, Jin Ho},
title = {ALK-positive adult histiocytosis with a TFG-ALK fusion gene},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf221}
}
EUVIMED